Skip to content
Sexually Transmitted Infections
Detect and identify 14 different causative pathogens
1,579,885

Chlamydia is the most frequently reported bacterial STI in the United States.

In 2020, a total of 1,579,885 cases of Chlamydia trachomatis infection were reported to the CDC, making it the most common notifiable sexually transmitted infection in the United States for that year.

Product Information
  • Analytes
    • Chlamydia trachomatis (CT)
    • Mycoplasma genitalium (MG)
    • Neisseria gonorrhoeae (NG)
    • Trichomonas vaginalis (TV)
    This product has multiple variants. The options may be chosen on the product page
  • Analytes
    • Herpes simplex virus type 1 (HSV-1)
    • Herpes simplex virus type 2 (HSV-2)
    • Cytomegalovirus (CMV)
    • Varicella-zoster virus (VZV)
    • C . trachomatis serovar L (LGV)
    • Treponema pallidum (TP)
    • Haemophilus ducreyi (HD)
    This product has multiple variants. The options may be chosen on the product page
  • Analytes
    • Chlamydia trachomatis (CT)
    • Neisseria gonorrhoeae (NG)
    • Mycoplasma genitalium (MG)
    • Mycoplasma hominis (MH)
    • Trichomonas vaginalis (TV)
    • Ureaplasma urealyticum (UU)
    • Ureaplasma parvum (UP)
    This product has multiple variants. The options may be chosen on the product page
Specimen

Genital swab
Oropharyngeal (throat) swab
Anorectal swab
Liquid-based cytology
Urine
Semen

Genital swab
Liquid based cytology
Urine

Genital swab
Oropharyngeal (throat) swab
Anorectal swab
Liquid-based cytology
Urine
Semen

Compatible instrumentation

Automated Extraction & PCR Setup
Seegene NIMBUS
Seegene STARlet

Real-time PCR
CFX96™ Real-time PCR System (Bio-Rad)
CFX96™ Dx Systems (Bio-Rad)
CFX96™ Opus (Bio-Rad)
CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad)

Seegene Viewer Software

  • Quick and easy data analysis and interpretation
  • Interface specialized for multiplex testing
Key Features
  • Simultaneous detection of multiple STI pathogens 
  • Short TAT (4 hours) from extraction to final results
  • Informative data with individual Ct value for each analyte
Understanding Sexually Transmitted Infections

Sexually transmitted infections (STIs) are among the most common infectious conditions and are a substantial cause of morbidity and mortality worldwide, with 1 million new curable cases every day. STIs severely impact sexual and reproductive health and can also be transmitted to sexual partners and newborns. STIs cause sexually transmitted diseases (STDs), such as chlamydia, gonorrhea, and trichomoniasis.

CT infection, the most common bacterial STI, causes several urogenital syndromes, including urethritis, epididymitis, prostatitis, and cervicitis.1 In some women, CT infections may ascend to the upper genital tract and become chronic, leading to long-term sequelae, such as reproductive complications including pelvic inflammatory disease (PID), ectopic pregnancy, tubal infertility, or inducing adverse pregnancy outcomes.2,3 CT infections are also associated with an increased risk of cervical cancer, HIV acquisition, and transmission.4 

Gonorrhea is the second most reported bacterial sexually transmitted infection in the United States. Urethral infections caused by NG can produce symptoms among men, but often not soon enough to prevent transmission to others.5 Among women, gonococcal infections are commonly asymptomatic or might not produce recognizable symptoms until complications have occurred.6

Seegene provides an extensive multiplex sexually transmitted infection (STI) test menu for use in research testing.

The Novaplex™ STI Essential Assay*, Novaplex™ Genital Ulcer Assay* and Novaplex™ CT/NG/MG/TV Assay* are multiplex, real-time RT-PCR assays that detect and identify 14 STI pathogens simultaneously.

Seegene offers two drug-resistance detection assays for M. genitalium. Both assays detect single DNA mutations that cause resistance as well as MG infection itself.  Both assays use exogenous IC for urine and endogenous IC for others. The Novaplex™ MG & AziR Assay* and the Novaplex™ MG & MoxiR Assay* are designed to be run together with the Novaplex™ CT/NG/MG/TV Assay*.

*Novaplex™ Assays are For Research Use Only. Not for Use in Diagnostic Procedures.

1 K Manavi. A review on infection with Chlamydia trachomatis. Best Pract Res Clin Obstet Gynaecol. 2006 Dec;20(6):941-51. doi: 10.1016/j.bpobgyn.2006.06.003. Epub 2006 Aug 24.
2 CL Haggerty et al., Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010 Jun 15;201 Suppl 2:S134-55. doi: 10.1086/652395.
3 A Ammerdorffer et al., Chlamydia trachomatis and chlamydia-like bacteria: new enemies of human pregnancies. Curr Opin Infect Dis. 2017 Jun;30(3):289-296. doi: 10.1097/QCO.0000000000000369.
4 K Adachi et al., Chlamydia and Gonorrhea in HIV-Infected Pregnant Women and Infant HIV Transmission. Sex Transm Dis. 2015 Oct;42(10):554-65. doi: 10.1097/OLQ.0000000000000340.
5 LM Valley et al., Adverse pregnancy and neonatal outcomes associated with Neisseria gonorrhoeae: systematic review and meta-analysis. Sex Transm Infect. 2021 Mar;97(2):104-111. doi: 10.1136/sextrans-2020-054653. Epub 2021 Jan 12.
6 KA Workowski et al., Sexually Transmitted Infections Treatment Guidelines, MMWR Recomm Rep 2021;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.
Back To Top
Search